AGO2 and lung carcinoma: Similar results were observed in A549 lung carcinoma cells (Fig 3D), HEK293T (Supplementary Fig. 3D) and MCF7 breast cancer cells (Supplementary Fig. 3E), where nuclear AGO2 and p53 accumulate in the cytoplasm after ATO treatment.